Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for immediate dental implants
NCT07003243Phase 1Not yet recruiting
- Sponsor
- University of Baghdad
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Mucomel in tooth loss (2 arms), sponsored by University of Baghdad. Primary endpoint: Change in crestal bone level around dental implants at 6 months. Planned start May 2025; status: not yet recruiting.
02
Drugs
Mucomel
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT07003243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07003243.